Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

Related Articles by Review for PubMed (Select 19846286)

1.

Effect of omalizumab on peripheral blood eosinophilia in allergic asthma.

Massanari M, Holgate ST, Busse WW, Jimenez P, Kianifard F, Zeldin R.

Respir Med. 2010 Feb;104(2):188-96. doi: 10.1016/j.rmed.2009.09.011. Epub 2009 Oct 20.

2.

Anti-IgE for chronic asthma in adults and children.

Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003559. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD003559.

PMID:
16625585
3.

Anti-IgE for chronic asthma in adults and children.

Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.

Cochrane Database Syst Rev. 2004;(3):CD003559. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD003559.

PMID:
15266491
4.

Anti-IgE for chronic asthma.

Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.

Cochrane Database Syst Rev. 2003;(3):CD003559. Review. Update in: Cochrane Database Syst Rev. 2004;(3):CD003559.

PMID:
12917972
5.

Omalizumab: a review of its use in the management of allergic asthma.

Bang LM, Plosker GL.

Treat Respir Med. 2004;3(3):183-99. Review.

PMID:
15219177
6.

Spotlight on omalizumab in allergic asthma.

Bang LM, Plosker GL.

BioDrugs. 2004;18(6):415-8. Review.

PMID:
15571425
7.

Targeting IgE in asthma.

Kuhl K, Hanania NA.

Curr Opin Pulm Med. 2012 Jan;18(1):1-5. doi: 10.1097/MCP.0b013e32834deebb. Review.

PMID:
22139745
8.

A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.

D'Amato G, Piccolo A, Salzillo A, Noschese P, D'Amato M, Liccardi G.

Recent Pat Inflamm Allergy Drug Discov. 2007 Nov;1(3):225-31. Review.

PMID:
19075985
9.

Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.

Holgate ST, Djukanović R, Casale T, Bousquet J.

Clin Exp Allergy. 2005 Apr;35(4):408-16. Review.

PMID:
15836747
10.

Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisal.

Burch J, Griffin S, McKenna C, Walker S, Paton J, Wright K, Woolacott N.

Pharmacoeconomics. 2012 Nov 1;30(11):991-1004. doi: 10.2165/11597160-000000000-00000. Review.

PMID:
22950547
11.

Effects of omalizumab on markers of inflammation in patients with allergic asthma.

Holgate S, Smith N, Massanari M, Jimenez P.

Allergy. 2009 Dec;64(12):1728-36. doi: 10.1111/j.1398-9995.2009.02201.x. Epub 2009 Oct 15. Review.

PMID:
19839977
12.

Omalizumab: a review of its use in the treatment of allergic asthma.

Plosker GL, Keam SJ.

BioDrugs. 2008;22(3):189-204. Review.

PMID:
18481901
13.

The role of omalizumab in the treatment of severe allergic asthma.

Chapman KR, Cartier A, Hébert J, McIvor RA, Schellenberg RR.

Can Respir J. 2006 Jul-Aug;13 Suppl B:1B-9B. Review.

14.

Anti-immunoglobulin E therapy with omalizumab for asthma.

Hendeles L, Sorkness CA.

Ann Pharmacother. 2007 Sep;41(9):1397-410. Epub 2007 Aug 14. Review.

PMID:
17698897
15.

Omalizumab: a review of its use in patients with severe persistent allergic asthma.

McKeage K.

Drugs. 2013 Jul;73(11):1197-212. doi: 10.1007/s40265-013-0085-4. Review.

PMID:
23812924
16.

Omalizumab: a recombinant humanized anti-IgE antibody for allergic asthma.

Ruffin CG, Busch BE.

Am J Health Syst Pharm. 2004 Jul 15;61(14):1449-59. Review.

PMID:
15332692
17.

The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update.

Holgate S, Buhl R, Bousquet J, Smith N, Panahloo Z, Jimenez P.

Respir Med. 2009 Aug;103(8):1098-113. doi: 10.1016/j.rmed.2009.03.008. Epub 2009 Apr 10. Review. Erratum in: Respir Med. 2010 Jun;104(6):924.

18.

Evaluation of omalizumab from a health plan perspective.

Belliveau PP, Lahoz MR.

J Manag Care Pharm. 2005 Nov-Dec;11(9):735-45. Review.

19.

Impact of omalizumab on quality-of-life outcomes in patients with moderate-to-severe allergic asthma.

Niebauer K, Dewilde S, Fox-Rushby J, Revicki DA.

Ann Allergy Asthma Immunol. 2006 Feb;96(2):316-26. Review.

PMID:
16498854
20.

Anti-IgE antibodies for the treatment of asthma.

Buhl R.

Curr Opin Pulm Med. 2005 Jan;11(1):27-34. Review.

PMID:
15591885
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk